Detalles de la búsqueda
1.
Efficacy of Salvage Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Including Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review and Meta-Analysis / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 1031-1047, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-999776
2.
Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 291-303, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-966496
3.
Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study bythe Consortium for Improving Survival of Lymphoma (CISL) / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 304-313, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-966487
4.
A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma:Incorporation of Serum β-2 Microglobulin to PINK / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 314-324, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-966486
5.
Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 1355-1362, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-999832
6.
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404) / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 684-692, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-976690
7.
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 325-333, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-966481
8.
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 597-612, 2022.
Artículo
en Inglés
| WPRIM | ID: wpr-925679
9.
Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
The Korean Journal of Internal Medicine
; : 668-678, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-903705
10.
Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
The Korean Journal of Internal Medicine
; : 668-678, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-896001
11.
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 847-856, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-897461
12.
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 847-856, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-889757
13.
Asian variant of intravascular large B-cell lymphoma: a comparison of clinical features based on involvement of the central nervous system
The Korean Journal of Internal Medicine
; : 946-956, 2020.
Artículo
| WPRIM | ID: wpr-831802
14.
Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective study
Blood Research
; : 85-90, 2020.
Artículo
| WPRIM | ID: wpr-830998
15.
Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance
The Korean Journal of Internal Medicine
; : 194-204, 2020.
Artículo
| WPRIM | ID: wpr-831768
16.
17.
Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 611-622, 2019.
Artículo
en Inglés
| WPRIM | ID: wpr-763133
18.
Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 547-555, 2019.
Artículo
en Inglés
| WPRIM | ID: wpr-763139
19.
Body Cavity–Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 1302-1312, 2019.
Artículo
en Inglés
| WPRIM | ID: wpr-763229
20.
Validation of the Korean Version of the Quality of Life–Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 204-211, 2018.
Artículo
en Inglés
| WPRIM | ID: wpr-739615